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neurotransmitter; vascular control; microspheres; thermal stress; laser Doppler flowmetry; venous occlusion plethysmography NEUROPEPTIDE Y (NPY) is a 36-amino acid peptide neurotransmitter that occurs, in separate vesicles, in the same sympathetic adrenergic fibers as does norepinephrine (NE) (8, 26) . It also coexists with vasoactive intestinal peptide (VIP) in peripheral non-noradrenergic neurons (25) , occurs in the adrenal medulla, and is one of the most abundant of all neuropeptides found in the brain (5, 39) .
Six NPY-receptor subtypes have been identified (5, 40) thus far. Studies using C-terminal peptide fragments of NPY at the synaptic cleft revealed two receptor subtypes (39) : Y 1 receptors, which were postsynaptic and occurred in the vascular smooth muscle, and Y 2 receptors, which were presynaptic and inhibited NE release (39) . Whereas Y 1 and Y 2 receptors showed similar affinities for NPY and peptide YY (PYY), a third receptor (Y 3 ) (1) showed different affinities for these neuropeptides. Recently, several more receptors (Y 4 , Y 5 , and Y 6 ) have been identified through cloning methods (13) (14) (15) .
NPY is highly vasoactive. Both peripheral and central administration alters cardiovascular function (39) . Increased blood pressure and resistance in peripheral vascular beds and other tissues, as well as reduced heart rate, have been reported (see 5, 37) . In vitro studies of the rat tail artery have shown that NPY caused a slow depolarization and concentration-dependent contraction via a direct effect on arterial smooth muscle cells (31) . In vivo studies, in humans and other mammals, have demonstrated marked reduction in blood flow (BF) in the human forearm, and in brain, heart, kidney, pancreas, thyroid, spleen, skeletal muscle, and intestine in response to exogenous NPY (27, 39) . NPY has been reported to cause constriction in both arteries (cerebral, coronary, skeletal muscle) and veins (iliac, femoral) in the guinea pig and rat (6) .
In striking contrast to these previous reports, Heath and Thomas (22) demonstrated that NPY caused a pronounced increase in total BF (BF tot ), as measured in the rat tail by venous occlusion plethysmography (VOP). The NPY-induced increase in BF tot was accompanied by a marked increase in tail volume, an increase in tail skin temperature (T sk ), but a decrease in superficial skin microvascular BF (BF sk ).
These observations suggest, for the following reasons, the hypothesis that arteriovenous anastomoses (AVAs) participate in the NPY-induced increase in BF tot . AVAs, which are abundant in the rat tail skin (12) , are relatively large-diameter connections between arteries and veins that allow an increase in nonnutrient ''thermoregulatory'' BF in the skin (12) . When AVAs in the skin open, there are increases in the volume of blood (22) , in total BF sk , and in T sk , because more heat is brought to the skin by the greater volume of blood flowing through it. There is also often a reduction in the microvascular BF through capillaries, as blood flows by another path of lesser resistance (20, 22) . These are exactly the changes observed in the rat tail in response to NPY (22) .
AVA BF is important in thermoregulatory mechanisms, such as cold-induced vasodilation and peripheral vasodilation during heat stress; these are potentially important to medical conditions such as non-freezing cold injury, heat syncope, and heat stroke. Therefore, further study of NPY-induced increase in BF tot in the rat tail is warranted. The specific aims of this study were to 1) document the dose-response relationship for tail BF (BF tot and BF sk ), 2) test the hypothesis that AVAs participate in the NPY-induced vasodilation, and 3) assess the NPY-receptor subtypes involved in the vasodilatory response through the use of the Y 1 -and Y 2 -receptor agonists ([Leu 31 Pro 34 ]NPY, and NPY , respectively).
METHODS
Animals and surgical preparation. Twenty-one male LongEvans rats (weighing 290-310 g) were studied. All rats were equipped with a cannula (S-26, ITT c Life Science) in a jugular vein, and some were equipped with a blind-ended reentrant tube sutured to the muscle adjacent to the carotid artery. A thermocouple was inserted into the reentrant tube for measures of body core temperature (T c ). These sterile surgical procedures were done while the rats were fully anesthetized with ϳ50 mg/kg pentobarbital sodium.
Measurements. 21) . So that hair would not interfere with laser Doppler, VOP BF, or T sk measurements, the hair was removed from the tail by using a depilatory.
Preparation for experiments. Rats were anesthetized with ϳ50 mg/kg pentobarbital sodium and were gently introduced into a cylindrical Plexiglas rat restrainer. The restrainer allowed free access to the hind legs and tail and to the end of the cannula and reentrant tube located between the shoulders. Tail BF tot is measured by using a pneumatic venous occlusion cuff, which must be positioned at the base of the tail, and a mercury-in-Silastic strain gauge that measures changes in volume of the tail during the periodic occlusions. The latter had to be positioned midway along the tail (e.g., 7-10 cm from base of the tail) to avoid artifacts either from being too close to the cuff or from being in a region (tail tip) where the radius is too small. A laser Doppler flow probe and a thermocouple were positioned on the skin adjacent to each other and as near to the strain gauge as possible (e.g., 6-8 cm from the base of tail). A BF sk reading of 5 ml · min Ϫ1 · 100 ml tissue Ϫ1 was used as the minimum acceptable baseline value. If BF sk was lower than this, then the laser Doppler probe was repositioned until an acceptable reading was obtained. All instrumentation was connected to an IBM-compatible computer via an analog-todigital converter (Keithley). Thermocouple and laser Doppler channels were sampled at 1-s intervals and averaged for 20 s. The VOP measure of tail BF tot was done at 20-s intervals. The occlusion cuff was inflated to 50-55 mmHg for 5 s, and tail BF tot was assessed between the 2nd and 4th s of the cuff inflation.
NPY, NE, [Leu 31 Pro 34 ]NPY, and NPY protocols. In preliminary studies, doses of 32 and 64 µg/kg of NPY were shown to result in plasma levels of 2.0-2.5 pmol/ml of NPY in 300-g rats. The range of plasma levels observed in rats is 0.3-0.4 pmol/ml in baseline (control) conditions, and 1.2-1.5 pmol/ml in conditions of cold stress induced by 30ϩ min of exposure to 4°C water (42) . Doses of 16 (n ϭ 5), 32 (n ϭ 5), 64 (n ϭ 7), or 128 (n ϭ 7) µg/kg NPY were, therefore, used in the present study to generate plasma levels similar to those found during stress in rats. The doses of [Leu 31 Pro 34 ]NPY (63.25 µg/kg) and NPY (44.7 µg/kg) administered were equimolar to 64 µg/kg of NPY (n ϭ 4). NE (n ϭ 2) was delivered in a dose of 400 µg/kg, a dose known to invoke its normal vasoconstrictive effect.
Fully instrumented rats rested in the restrainer for 15-30 min before the intravenous administration of NPY (16, 32, 64 or 128 µg/kg), NE (400 µg/kg), the Y 1 -receptor agonist [Leu 31 Pro 34 ]NPY (63.25 µg/kg), the Y 2 -receptor agonist NPY (44.7 µg/kg), or saline control. The volume of all injections was 300 µl, and injections were delivered over a 2-min period. Baseline recording was begun 5 min preceding the injection, and measurements were continued for at least 35 min postinjection. All experiments were done at T a of 24-26°C.
Use of color microspheres to assess NPY effect on AVAs. Color microspheres (Interactive Medical Technologies, Los Angeles, CA) of 15-µm diameter were used to assess whether AVAs in the rat tail are involved in the NPY-induced increase in BF tot . Microspheres of this diameter can pass through AVAs but will be caught in the smaller diameter capillaries. Thus microspheres infused into the blood supply of the tail will end up in one of two places. Either they pass through AVAs in the rat tail and, after passing through the heart, end up in the capillaries of the lungs, or they will be caught in the capillaries of the tail tissues.
For these experiments, a second cannula was surgically introduced into the arterial blood supply to the tail, in the distal region of the descending aorta, well distal to the major blood supply to the hindlimbs, and just proximal to the caudal artery. Most microspheres infused via this cannula must flow into the caudal artery. The only other possibility is the very few vessels feeding the skin and muscle tissues of caudalmost region of the body, in which case the microspheres would either be trapped in those capillary beds or pass through AVAs and be trapped in the lungs. Successful experiments were completed on eight rats. Approximately 0.5 million color microspheres of 15-µm diameter were infused in the arterial cannula 1-2 min after administration of saline (300 µl iv; red microspheres; control) and 1-2 min after a subsequent administration of NPY (64 µg/kg in 300 µl iv; violet microspheres). The rats were killed 10 min after completion of the injection protocol. Tissue samples of the lung and skin midway along the tail (a section from 4-to 10-cm from base of tail) were taken immediately and sent to Interactive Medical Technologies. The number of microspheres of each color present in the tissue samples was counted by and reported by Interactive Medical Technologies.
Data presentation and statistical analysis. The data collected at 1-min intervals are provided from one representative experiment in which NPY, NE, [Leu 31 Pro 34 ]NPY, and NPY were administered. To summarize the BF tot and BF sk responses to NPY, the mean values for each 5-min period, including baseline and up to 40 min postadministration, were calculated for each experiment. The mean Ϯ SD of the responses for each dose of NPY and for physiological saline were then calculated. Analysis of variance (not repeated measures) and Dunnett's multiple-comparison test were used to assess whether the BF tot and BF sk responses to different doses of NPY were significantly different from responses to saline (control) administration. Dunnett's test is appropriately used when one data group is the control (saline) to which all other groups are compared. Paired t-tests were used to assess whether there were more microspheres in the lung than in the tail skin tissue after saline and NPY administration (n ϭ 8). Figure 1 (left) illustrates the effects of 64 µg/kg exogenous NPY on (top to bottom) BF tot , BF sk , and T sk in the rat tail in one experiment. The effect of NPY has an immediate pronounced dynamic phase that is of short duration and is followed by a prolonged and less pronounced static phase. The dynamic phase included an immediate marked increase in tail BF tot and tail volume that peaked within 1-3 min. Concurrent with the increase in BF tot is an increase in tail T sk , and a consistent 1-3% increase in total tail volume (not shown) is observed as a pronounced upward shift in the baseline of the analog and digitized plethysmographic record. In contrast, BF sk in the tail declined to Ͻ50% of baseline within 1-3 min, and T c declined by up to 1.5°C. This dynamic phase ended as the values of all parameters moved toward baseline levels, albeit without fully achieving them. In the subsequent static phase, that continued throughout the rest of the experiment, BF tot remained somewhat elevated and BF sk remained somewhat depressed.
RESULTS

Effect of NPY on BF and body temperatures.
The effect of exogenous NE (400 µg/kg) on these same variables is presented in Fig. 1 (right) for comparison. NE invokes marked reductions in both BF tot and BF sk due to vasoconstriction and has no effect on tail T sk . In comparison, the marked increase in BF tot after NPY administration suggests that NPY dilates some vessels in the tail. However, the reduction in BF sk at the same time indicates that this increase in BF does not involve the cutaneous microvascular bed.
Dose-response relationships. Figure 2A illustrates Figure 2B illustrates the dose-response relationship between NPY and BF sk . NPY caused a clear and marked reduction in BF sk , the magnitude of which was dose dependent. The reduction in BF sk was not significant for 16 µg/kg (P Ͼ 0.05) but was significant for both 32 and 64 µg/kg (P Ͻ 0.01) when values were compared at minutes 20-25 of the experiment. It should be noted that the laser Doppler flowmeter used for measuring micovascular BF is limited to making that measurement at only one small area. However, given the consistency of the response during multiple experiments, this measurement is likely to be representative of what is occurring throughout the skin.
Microsphere studies. Microspheres were used to test the hypothesis that AVAs dilate and participate in the NPY-induced increased BF tot . Figure 3 shows the number (mean Ϯ SD) of microspheres/g tissue reaching the tail skin (left) and lung (right) after normal administration of saline (300 µl iv; control) or 64 µg/kg NPY in a 300-µl injection. After saline, 14,080 Ϯ 10,420 microspheres/g tissue were found in the lung. Significantly more microspheres (40,571 Ϯ 26,790/g tissue; P Ͻ 0.01) were found in the lung after administration of NPY. Furthermore, the number of microspheres trapped in the tail skin tissue is actually higher (P Ͻ 0.005) after saline (2,988 Ϯ 2,010/g tissue) than after NPY (1,496 Ϯ 1,223/g tissue) administration. This is as expected, considering the reduced microvascular BF sk measured by laser Doppler flowmeters. These results demonstrate the participation of AVAs in the NPY-induced increase in rat tail BF tot .
Effect of [Leu 31 Pro 34 ]NPY and NPY on BF and body temperatures. Figure 4 illustrates the effects of [Leu 31 Pro 34 ]NPY (the Y 1 -receptor agonist) and of NPY (the Y 2 -receptor agonist), respectively, on tail BF tot and BF sk in the tail. Clearly, the Y 1 -receptor agonist has a similar effect to that of NPY (compare with Fig. 1) . In marked contrast, the Y 2 -receptor agonist has no effect on either tail BF tot or BF sk in the tail. These results suggest that Y 1 receptors, or receptors responsive to Y 1 agonist, participate in the NPYinduced increase in BF tot and concurrent decreases in BF sk . The results also indicate that Y 2 receptors are not involved in this increased BF.
DISCUSSION
The results of these studies demonstrate that exogenous NPY, administered at physiological levels, consistently invokes in the rat tail an increase in BF tot , tail blood volume, and tail T sk , and a decrease in tail BF sk . It is further demonstrated that there is a dose-response relationship for both BF tot and BF sk and that the increase in BF tot is caused by a pronounced vasodilation in which AVAs play a role. Finally, this NPY-induced vasodilation is also invoked by the Y 1 -receptor agonist, [Leu 31 Pro 34 ]NPY, but not by a Y 2 -receptor agonist, NPY . The discussion that follows examines these observations and conclusions in some detail.
Clear evidence of NPY-induced increase in BF tot . The present study provides unrefutable evidence that physiological levels of NPY induce increases in BF tot in the rat tail. This is because the method used to measure BF tot (VOP) is a direct, quantitative, and frequently used measure that cannot provide a false indication of such increases in BF tot . The observation is supported further by the concurrent increase in tail (blood) volume and tail T sk , notwithstanding the reduction in superficial microvascular tail BF sk . It should be noted that such decreases in microvascular or capillary BF have often been observed when blood flows by another path of lesser resistance (20, 22) . The conclusion that some vessels in the tail dilate in response to exogenous NPY is supported by the observed simultaneous increase in tail blood volume and BF tot .
AVAs. AVAs are relatively large-diameter connections between arteries and veins that allow an increase in non-nutrient thermoregulatory BF through the skin (12) . They are opened during heat stress (19) . They are also thought to open, periodically, during exposure to extreme cold to prevent tissue freezing (commonly referred to as cold-induced vasodilation) (10) .
AVAs are the most likely vascular tissue to be involved in the NPY-induced increase in BF tot , because of the several reasons already enumerated in the introduction and the following additional reasons. The possibility that the dilation occurs in arteries, arterioles, venules, and veins is rejected, because the subsequent flow through capillaries would be a limiting factor and because it has already been demonstrated that capillary BF in the skin is reduced rather than increased. The observed increase in blood volume could be explained by pooling of blood in compliant veins, but that cannot explain the increased tail BF. AVAs are known to occur in large numbers in the rat tail (12) . In addition, the rat tail is the only one of many peripheral tissues studied where NPY causes increases in BF tot associated with vasodilation, and it is the only one of these tissues that is known to have abundant AVAs.
Evidence supporting the hypothesis that AVAs participate in the NPY-induced increase in BF tot in the rat tail. That AVAs are involved in the NPY-induced increase in BF tot in the rat tail is convincingly demonstrated by the results of the experiments using color microspheres (Fig. 3) . Blood flowing through the arterial vessels of the tail will end up in the veins by passing either Fig. 3 . Results of microsphere study. Color microspheres, 15 µm in diameter, were infused into blood supply to rat tail 1 min after saline or NPY administration. Tissue samples were taken from tail skin (4-10 cm from base of tail) and lung tissue to quantitatively assess no. of microspheres trapped in each tissue. Microspheres reaching lung must have passed through larger vessels, such as arteriovenous anastomoses (AVAs) in rat tail to move from arterial vasculature to venous vasculature. Many times more microspheres reach lung after NPY than after saline administration. This indicates that NPY causes increased blood flow through rat tail via AVAs. http://jap.physiology.org/ through capillaries that are 2-3 µm in diameter or through AVAs that are 20-50 µm in diameter. Whereas 15-µm-diameter microspheres easily pass through AVAs, they are trapped in the capillary beds. The fact that the number of microspheres ending up in the lung tissue is severalfold greater after NPY administration than after the administration of saline clearly indicates that AVAs participate in the NPY-induced increase in BF tot in the rat tail. Furthermore, the decline in the number of color microspheres trapped in the capillaries of the tail skin after NPY administration, compared with after saline administration, reaffirms the decline in microcirculatory BF sk after NPY administration, as measured locally by the laser Doppler flowmeter. (Fig. 4, left) has an effect that is essentially identical to that of NPY (compare with Fig.  1, left) . In marked contrast, the Y 2 -receptor agonist (Fig. 4, right) Finding an NPY-induced increase in BF tot in the rat tail was initially unexpected in light of the numerous reports that NPY causes either vasoconstriction or no change in vascular tone in blood vessels and that NPY reduced BF in the organs and tissues heretofore studied (8, 11, 34) . NPY has also been shown to cause systemic hypertension (7) . Thus one plausible explanation for the increased BF tot is that it is due to an elevation in blood pressure that is caused by vasoconstriction in other tissues. Although the present study did not measure blood pressure, two observations con- http://jap.physiology.org/ flict with this explanation. First, microvascular BF sk should have increased rather than decreased with elevations in blood pressure. Second, although an increase in blood pressure can increase BF through vessels, it cannot increase BF through AVAs unless the AVAs are already open. Thus we return to the conclusion that NPY, either directly or indirectly, is affecting AVA tone. In addition, it should be noted that high doses (Ͼ3 nM/kg) of NPY are reported to decrease mean arterial pressure because of release of histamine from mast cells (17) . The timing of the reported hypotension response (1-to 12-min postinjection) correlates well with the timing of the increased tail BF tot observed in the present study.
Also, the present observations seem to be in direct conflict with the finding by Neild (31) that NPY causes vasoconstriction in the isolated-vessel preparations of the rat tail artery. There are, however, several plausible reasons why the vasoconstriction observed in that isolated rat tail artery preparation was not observed in the present study and why those results should not be extrapolated to the whole animal. First, the plasma levels of NPY (1.5-2.5 pmol/kg) used in the present study were much lower than the 20-30 nM doses used to perfuse the isolated rat tail artery (31) and may not, therefore, have been great enough to cause constriction in the artery. Second, it should be understood that, although isolated vessel preparations can provide much insight about the pharmacology of a given vessel, such preparations do not fully mimic the conditions in the whole animal. Third, the vasculature of the rat tail is complex, with not just one, but several, arteries traversing its length, and there are numerous anastomoses between those arteries (31) . Thus the actual route of arterial BF can be shifted between different arteries. It is possible that the ventral medial artery studied by Neild (31) responds differently to NPY than do the several lateral or collateral arteries or the anastomose connecting them. Finally, because AVAs are involved and because they are highly specialized vascular structures, unlike any of the other vascular tissues in which the response to NPY has been studied, it is not surprising that they would have unique responses to NPY or other pharmacological agents. Indeed, AVAs could not perform their unique function of altering the route of BF to increase both the flow and volume of blood in the skin in response to the specific conditions of heat stress if they were pharmacologically identical to arteries. The pharmacological mechanism involved in the control of BF through AVAs is not fully understood, although one report suggests the involvement of ␣ 1 -adrenergic receptors in pig AVAs (4).
The most obvious explanation for the observed increase in BF tot via AVAs in response to NPY is that NPY acts at the presynaptic level to inhibit NE release, which subsequently results in relaxation of AVA tone. This conclusion is based on the following several observations. First, there is evidence that AVA tone is maintained by the sympathetic nervous system via action of NE (19, 30) on adrenergic receptors, as demonstrated in studies on dogs and sheep (18, 23) . In addition, a more recent study has more specifically implicated the involvement of ␣ 1 -adrenergic receptors in regulating BF through AVAs in pigs (4). Second, NPY has been shown both to inhibit NE release by its presynaptic action on Y 2 receptors and also to postsynaptically potentiate the vasoconstriction induced by NE by action on Y 1 receptors (34) . One problem with this hypothesis is that our results indicate that NPY acts on Y 1 receptors, which were previously reported to be postsynaptic (38) , rather than Y 2 receptors, which were reported to be presynaptic (38) . However, more recent studies have demonstrated that Y 1 receptors occur presynaptically and that Y 2 receptors occur postsynaptically (16, 29) . Thus it is possible that Y 1 receptors could be presynaptic in a specialized tissue, such as AVAs, where NPY causes dilation rather than vasoconstriction.
In more recent studies, it was shown that both Y 1 and Y 2 receptors occur in arterioles in intestinal submucosa of guinea pigs (32) and in the microvascular tree in the hamster cheek pouch (2). Neild and Lewis (32) observed that a Y 1 -receptor agonist caused a greater potentiation of a vasoconstriction response to short pulses of K ϩ than to NPY per se, and, furthermore, that a Y 2 -receptor agonist reduced the magnitude of vasoconstriction. This differs from the inhibition of NE release presynaptically. Rather, the Y 2 agonist PYY-(13-36) is acting on Y 2 receptors on the smooth muscle to modulate the opening of the Ca 2ϩ channels, just as they do in nerve terminals (9) .
Clearly, further study is needed to characterize definitively the receptors involved, to ascertain whether they are presynaptic or postsynaptic, and to understand the pharmacological mechanism responsible for the observed NPY-induced increase in tail BF tot . On the basis of other reports in the literature, the possibility clearly remains that other receptor types and vasoactive substances are involved in the pharmacology of this mechanism. For example, NPY has also been found to be costored with ACh in parasympathetic nerves (35) and possibly to modulate ACh secretion (24) . This is relevant, because ACh is a known vasodilator substance. Also, as mentioned above, larger doses of NPY have caused release of histamine from mast cells, which, due to the vasodilatory effects of histamine, resulted in hypotension (17) . Finally, the potentiation of the vasoconstriction response induced by NE (34) is dependent on both endothelium and Ca 2ϩ (3) and independent of adrenergic receptors (28) . This opens the possible involvement of Ca 2ϩ channels and endothelium-derived relaxing factor, which some investigators believe is nitric oxide (33) or nitrosothiol (41) . Thus there are several plausible mechanisms by which NPY could invoke vasodilation in the rat tail, and it is clear that other neurotransmitters in addition to NPY and other receptors in addition to Y 1 receptors could be involved in this response.
